(Q43546600)

24 November 2017

title

Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype (English)

1 reference

24 November 2017

0 references

1 reference

6

1 reference

24 November 2017

7

1 reference

24 November 2017

Hasib Salah-Uddin

1

1 reference

24 November 2017

Elizabeth Scarr

2

1 reference

24 November 2017

Geoffrey Pavey

3

1 reference

24 November 2017

Kriss Harris

4

1 reference

24 November 2017

Jim J Hagan

5

1 reference

24 November 2017

Jeannette M Watson

8

1 reference

24 November 2017

language of work or name

English

0 references

publication date

29 April 2009

1 reference

24 November 2017

published in

Neuropsychopharmacology

1 reference

24 November 2017

volume

34

1 reference

24 November 2017

issue

9

1 reference

24 November 2017

page(s)

2156-2166

1 reference

G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

The discovery of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Cholinergic systems and schizophrenia: primary pathology or epiphenomena?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Levels of G-protein alpha q/11 subunits and of phospholipase C-beta(1-4), -gamma, and -delta1 isoforms in postmortem human brain caudate and cortical membranes: potential functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Comparison of the in-vivo muscarinic cholinergic receptor availability in patients treated with clozapine and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Discovery of an ectopic activation site on the M(1) muscarinic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

7 January 2021

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

7 January 2021

Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

7 January 2021

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

7 January 2021

Towards a muscarinic hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

7 January 2021

M1 Receptor Agonism, a Possible Treatment for Cognitive Deficits in Schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.41

7 January 2021

Identifiers

DOI

10.1038/NPP.2009.41

1 reference

Dimensions Publication ID

24 November 2017

1020950767

0 references

1 reference